New drug kills flu virus in one day, gets fast-tracked to approval

Welcome news as the flu pandemic begins to subside.

Tamiflu (generic: oseltamivir), the go-to drug for combatting influenza has a new challenger


Japanese drugmaker Shionogi has announced that test results are in: its drug kills the flu virus in 24 hours. With one pill. 

The drug, named Xofluza (generic: baloxavir marboxyl), was recently granted accelerated approval by the Japanese government after trials of the drug showed great promise. 

In a year that’s seen an epidemic—even pandemic—of flu cases, some resulting in unexpected deaths of people not in high-risk groups, the influenza outbreak in the United States this year has reached levels not seen since the swine flu epidemic of 2009. 

Though it likely won't be for sale until May 2018 in Japan and not in the United States until 2019 or very late 2018, it could be a sign of better news to come. 

How does it work?

The key is that by inhibiting the enzyme that the flu virus needs in order to replicate, it kills the virus within a human in 24 hours. The symptoms continue for about the same amount of time as when Tamiflu is used, however, but they’re lessened and begin to go away faster. And both drugs lessen the effects of the flu versus no drug at all. 

Tamiflu-maker Roche was involved in the study and development so it will be the company marketing this, in addition to Tamiflu—at least in the United States.

Given that the flu vaccine this season was only 36% effective, this is especially welcome news. 

Stand up against religious discrimination – even if it’s not your religion

As religious diversity increases in the United States, we must learn to channel religious identity into interfaith cooperation.

Sponsored by Charles Koch Foundation
  • Religious diversity is the norm in American life, and that diversity is only increasing, says Eboo Patel.
  • Using the most painful moment of his life as a lesson, Eboo Patel explains why it's crucial to be positive and proactive about engaging religious identity towards interfaith cooperation.
  • The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
Keep reading Show less

NASA's idea for making food from thin air just became a reality — it could feed billions

Here's why you might eat greenhouse gases in the future.

Jordane Mathieu on Unsplash
Technology & Innovation
  • The company's protein powder, "Solein," is similar in form and taste to wheat flour.
  • Based on a concept developed by NASA, the product has wide potential as a carbon-neutral source of protein.
  • The man-made "meat" industry just got even more interesting.
Keep reading Show less

Where the evidence of fake news is really hiding

When it comes to sniffing out whether a source is credible or not, even journalists can sometimes take the wrong approach.

Sponsored by Charles Koch Foundation
  • We all think that we're competent consumers of news media, but the research shows that even journalists struggle with identifying fact from fiction.
  • When judging whether a piece of media is true or not, most of us focus too much on the source itself. Knowledge has a context, and it's important to look at that context when trying to validate a source.
  • The opinions expressed in this video do not necessarily reflect the views of the Charles Koch Foundation, which encourages the expression of diverse viewpoints within a culture of civil discourse and mutual respect.
Keep reading Show less